Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk
Por:
Padro, T, Vilahur, G, Sanchez-Hernandez, J, Hernandez, M, Antonijoan, RM, Perez, A, Badimon, L
Publicada:
1 may 2015
Resumen:
The benefits of dietary phytosterols (PhySs) and long-chain n-3 PUFA (omega 3) have been linked to their effects as cholesterol-and triglyceride (TGL)-lowering agents. However, it remains unknown whether these compounds have further metabolic effects on LDL lipid composition. Here, we studied the effects of PhyS-or omega 3-supplemented low-fat milk (milk) on the LDL-lipidome. Overweight and moderately hypercholesterolemic subjects (n = 32) were enrolled in a two-arm longitudinal crossover study. Milk (250 ml/day), enriched with either 1.57 g PhyS or 375 mg omega 3 (EPA + DHA), was given to the participants during two sequential 28 day intervention periods. Compared with baseline, PhyS-milk induced a higher reduction in the LDL cholesterol (LDLc) level than omega 3-milk. LDL resistance to oxidation was significantly increased after intervention with PhyS-milk. Changes in TGL and VLDL cholesterol were only evident after omega 3-milk intake. Lipidomic analysis revealed a differential effect of the PhyS-and omega 3-milk interventions on the LDL lipid metabolite pattern. Content in LDL-glycerophospholipids was reduced after PhyS-milk intake, with major changes in phosphatidylcholine (PC) and phosphatidylserine subclasses, whereas omega 3-milk induced signifi cant changes in the long-chain polyunsaturated cholesteryl esters and in the ratio PC36: 5/lysoPC16: 0, associated to a reduced inflammatory activity. In conclusion, daily intake of milk products containing PhyS or omega 3 supplements induce changes in the LDL-lipidome that indicate reduced inflammatory and atherogenic effects, beyond their LDLc-and TGL-lowering effects.
Filiaciones:
Padro, T:
IIB St Pau, Hosp St Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain
Vilahur, G:
IIB St Pau, Hosp St Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain
Sanchez-Hernandez, J:
IIB St Pau, Hosp St Pau, Dept Endocrinol, Barcelona, Spain
Hernandez, M:
IIB St Pau, Hosp St Pau, CAPSA FOOD Nutr Dept, Barcelona, Spain
Antonijoan, RM:
IIB St Pau, Hosp St Pau, Medicament Res Ctr CIM, Barcelona, Spain
Perez, A:
IIB St Pau, Hosp St Pau, Dept Endocrinol, Barcelona, Spain
Badimon, L:
IIB St Pau, Hosp St Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain
Autonomous Univ Barcelona, Cardiovasc Res Chair, Barcelona, Spain
Green Published, hybrid
|